Gupta Rishi bought ELVN
February 12, 2026 · Form 4 insider transaction
Gupta Rishi bought 33,989 shares of Enliven Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
33,989
Price
$0.00
Total value
N/A
InsiderGupta Rishi
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2026
Filing dateFebruary 17, 2026
Shares owned after33,989
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/36th of the shares subject to the option vest on February 2, 2026 and each month thereafter, subject to the Reporting Person continuing as a non-employee director through the applicable vesting date.